Related Experiment Video
Updated: May 7, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Immune senescence and vaccination in the elderly
Pierre Olivier Lang1, Sheila Govind, Annemieke Ten Bokum
1Nescens Centre of preventive medicine c/o Clinique of Genolier - Rue du Muids, 3 - CH-1272 Genolier, Switzerland. polang@nescens.com.
Abstract:
Vaccines are powerful public health tools that have been of tremendous benefit in protecting vulnerable populations worldwide from many pathogens. However, vaccine- preventable diseases still remain a considerable burden and this is particularly true among aging and aged populations in industrialized countries. The predicted demographic shift in the population landscape towards an ever-increasing aging population and the evidence suggesting that older individuals mount less-than optimal immune response to vaccination have raised the question of improving vaccine responses in older individuals. This review presents recent progress in the understanding at the cellular and molecular levels of age related immune decline and strategies to translate current knowledge into the development of immunization strategies to promote healthy aging, keeping older members of our society autonomous and independent.
Related Concept Videos
Vaccinations
Replicative Cell Senescence
Replicative Cell Senescence
Drug Dosing: Geriatric Patients
The Effect of Aging on Tissues
Vaccines
